Is NVP-LDE225 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use NVP-LDE225? Is NVP-LDE225 safe for nursing mother and child? Does NVP-LDE225 extracts into breast milk? Does NVP-LDE225 has any long term or short term side effects on infants? Can NVP-LDE225 influence milk supply or can NVP-LDE225 decrease milk supply in lactating mothers?
Answer by DrLact: About NVP-LDE225 usage in lactation
No information is available on the clinical use of NVP-LDE225 during breastfeeding. Because NVP-LDE225 is 97% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is about 28 days and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during NVP-LDE225 therapy.
Alternate Drugs
Cisplatin(Unsafe)
Imatinib(Unsafe)
Ipilimumab(Unsafe)
Busulfan(Dangerous)
Nivolumab(Unsafe)
Cetuximab(Unsafe)
Vinblastine(Dangerous)
Azelaic Acid(Safe)
Carboplatin(Dangerous)
Bleomycin(Dangerous)
Paclitaxel(Dangerous)
Vinorelbine(Dangerous)
Gemcitabine(Dangerous)
Cladribine(Dangerous)
Fluorouracil(Dangerous)
Letrozole(Dangerous)
Dacarbazine(Dangerous)
Alemtuzumab(Low Risk)
Dactinomycin(Dangerous)
Exemestane(Dangerous)
Erlotinib(Unsafe)
Rituximab(Low Risk)
Vincristine(Dangerous)
Tamoxifen(Dangerous)
Dasatinib(Unsafe)
Bevacizumab(Low Risk)
Thioguanine(Dangerous)
Mitoxantrone(Dangerous)
Docetaxel(Dangerous)
Mercaptopurine(Safe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Hydroxyurea(Low Risk)
Etoposide(Dangerous)
Trastuzumab(Unsafe)
Doxorubicin(Dangerous)
Cyclophosphamide(Dangerous)
Gemcitabine(Dangerous)
Erlotinib(Unsafe)
Allopurinol(Safe)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Erlotinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)